Original Research

Published on 21 Apr 2022

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer

in Cancer Immunity and Immunotherapy

Chao Liu
Peiliang Wang
Yi Sun
Xue Dou
Xiaoyu Hu
Wenxue Zou
Yanlai Sun
Qinyong Hu
Jinbo Yue

Frontiers in Oncology

doi 10.3389/fonc.2022.756811

2,971 views
8 citations

Original Research

Published on 21 Apr 2022

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features

in Cancer Immunity and Immunotherapy

Leidi Xu
Ning Chang
Tingyi Yang
Yuxiang Lang
Yong Zhang
Yinggang Che
Hangtian Xi
Weiqi Zhang
Qingtao Song
Ying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.883543

2,449 views
2 citations

Original Research

Published on 20 Apr 2022

ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma

in Cancer Immunity and Immunotherapy

Tingting Deng
Yang Liu
Jialang Zhuang
Yizhe Tang
Qin Huo

Frontiers in Oncology

doi 10.3389/fonc.2022.632042

4,766 views
9 citations

Review

Published on 19 Apr 2022

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

in Cancer Immunity and Immunotherapy

Amin Daei Sorkhabi
Aila Sarkesh
Hossein Saeedi
Faroogh Marofi
Mahnaz Ghaebi
Nicola Silvestris
Behzad Baradaran
Oronzo Brunetti

Frontiers in Oncology

doi 10.3389/fonc.2022.818447

4,016 views
12 citations

Mini Review

Published on 14 Apr 2022

LAG3-PD-1 Combo Overcome the Disadvantage of Drug Resistance

in Cancer Immunity and Immunotherapy

Yiming Wei
Zhaoming Li

Frontiers in Oncology

doi 10.3389/fonc.2022.831407

9,735 views
19 citations

Original Research

Published on 08 Apr 2022

Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

in Cancer Immunity and Immunotherapy

Jian Qin
Yusheng Huang
Hanjing Zhou
Shouhui Yi

Frontiers in Oncology

doi 10.3389/fonc.2022.807102

3,633 views
28 citations

Correction

Published on 07 Apr 2022

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

in Cancer Immunity and Immunotherapy

Xiaoxiang Rong
Jinyu Lv
Yantan Liu
Zhaojun Wang
Dongqiang Zeng
Yuedan Li
Shaowei Li
Jianhua Wu
Zheyu Shen
Min Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.895938

1,604 views
1 citation

Case Report

Published on 06 Apr 2022

Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer

in Cancer Immunity and Immunotherapy

Manasa Anipindi
Ryan J. Smith
Madiha Gilani

Frontiers in Oncology

doi 10.3389/fonc.2022.856944

2,774 views
3 citations

Review

Published on 05 Apr 2022

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Ezgi Elmas
Noushin Saljoughian
Marcelo de Souza Fernandes Pereira
Brian P. Tullius
Kinnari Sorathia
Robin J. Nakkula
Dean A. Lee
Meisam Naeimi Kararoudi

Frontiers in Oncology

doi 10.3389/fonc.2022.834002

14,995 views
17 citations

Review

Published on 04 Apr 2022

Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology

in Cancer Immunity and Immunotherapy

Yawei Bao
Yong Cheng
Wei Liu
Wenguang Luo
Peijie Zhou
Dong Qian

Frontiers in Oncology

doi 10.3389/fonc.2022.845346

3,029 views
5 citations

Review

Published on 01 Apr 2022

Novel Immunotherapies for Osteosarcoma

in Cancer Immunity and Immunotherapy

Yubao Lu
Jiahe Zhang
Yutong Chen
Yuchen Kang
Zhipeng Liao
Yuanqi He
Cangyu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.830546

12,545 views
36 citations

Case Report

Published on 01 Apr 2022

Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report

in Cancer Immunity and Immunotherapy

Yi Feng
Chengyang Li
Yuan Ji
Ying Liu
Lu Gan
Yiyi Yu
Tianshu Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.801924

3,625 views
4 citations

Original Research

Published on 01 Apr 2022

The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Yohei Asano
Norio Yamamoto
Satoru Demura
Katsuhiro Hayashi
Akihiko Takeuchi
Satoshi Kato
Shinji Miwa
Kentaro Igarashi
Takashi Higuchi
Hirotaka Yonezawa

Frontiers in Oncology

doi 10.3389/fonc.2022.871675

5,134 views
17 citations

Review

Published on 31 Mar 2022

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer

in Cancer Immunity and Immunotherapy

Mohammad Fereydouni
Mona Motaghed
Elnaz Ahani
Tal Kafri
Kristen Dellinger
Dean D. Metcalfe
Christopher L. Kepley

Frontiers in Oncology

doi 10.3389/fonc.2022.830199

3,627 views
10 citations

Original Research

Published on 31 Mar 2022

Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy

in Cancer Immunity and Immunotherapy

Ronglin Wang
Yongdong Guo
Peixiang Ma
Yang Song
Jie Min
Ting Zhao
Lei Hua
Chao Zhang
Cheng Yang
Jingjie Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.851766

2,663 views
6 citations

Original Research

Published on 31 Mar 2022

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study

in Cancer Immunity and Immunotherapy

Zixiong Li
Ning Han
Xueying Ren
Yuanjing Zhang
Xiaoyuan Chu

Frontiers in Oncology

doi 10.3389/fonc.2022.833884

3,302 views
12 citations

Navigation group

Articles

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features

ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

LAG3-PD-1 Combo Overcome the Disadvantage of Drug Resistance

Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

Case Report: Immune Checkpoint Inhibitors as a Single Agent in the Treatment of Metastatic Cervical Cancer

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy

Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology

Novel Immunotherapies for Osteosarcoma

Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report

The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer

Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy

Effectiveness of TKI Inhibitors Combined With PD-1 in Patients With Postoperative Early Recurrence of HCC: A Real-World Study